Cite Filings / ACAD / 0000950170-23-004757

Feed Companies Filings Check

Sign in

10-K

Annual Report

ACADIA PHARMACEUTICALS INC Filed 2023-02-28 Acc 0000950170-23-004757

Documents 1

10-K Annual Report , acad-20221231.htm

Around this filing

2024-02-28 10-K Annual Report
2023-02-28 10-K Annual Report
2023-02-28 8-K Results of operations
2023-02-27 4 CEO sold 3,851 shares at $18.78 ($72,322)
2023-02-27 4 Principal Accounting Officer sold 350 shares at $18.78 ($6,573)
2023-02-27 4 EVP, Chief Financial Officer sold 577 shares at $18.78 ($10,836)
2022-03-01 10-K Annual Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading acad-20221231.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…